Sofio
Glucose Monitoring (Diabetes Management)
Pre-clinical/DevelopmentActive
Key Facts
Indication
Glucose Monitoring (Diabetes Management)
Phase
Pre-clinical/Development
Status
Active
Company
About GlucoModicum
GlucoModicum is pioneering needle-free glucose monitoring through its novel magnetohydrodynamic (MHD) technology platform. Its first product, Sofio, is a modular, single-day wearable monitor designed to provide clear glucose insights without the need for needles or long-term sensor commitments. As a private, pre-revenue spinout, the company combines clinical research, engineering, and industrial development expertise to bring this disruptive solution to the large and growing diabetes market. Its success hinges on clinically validating and scaling its unique physics-based sensing approach.
View full company profile